These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 3004720)
1. Primary Epstein-Barr virus-positive mixed neuroendocrine carcinoma of the nasopharynx: An unusual case report. Han L; Liu Y; Lv M; Zhong J Asian J Surg; 2024 Feb; 47(2):1049-1050. PubMed ID: 37957042 [No Abstract] [Full Text] [Related]
2. MUC1 induced by Epstein-Barr virus latent membrane protein 1 causes dissociation of the cell-matrix interaction and cellular invasiveness via STAT signaling. Kondo S; Yoshizaki T; Wakisaka N; Horikawa T; Murono S; Jang KL; Joab I; Furukawa M; Pagano JS J Virol; 2007 Feb; 81(4):1554-62. PubMed ID: 17151127 [TBL] [Abstract][Full Text] [Related]
3. Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines. Sato H; Takimoto T; Tanaka S; Tanaka J; Raab-Traub N J Virol; 1990 Nov; 64(11):5295-300. PubMed ID: 2170673 [TBL] [Abstract][Full Text] [Related]
4. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor. Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992 [TBL] [Abstract][Full Text] [Related]
5. The difference in tumorigenicity between Epstein-Barr virus (EBV) genome-positive and genome-negative epithelial hybrid cell lines derived from the human nasopharynx. Takimoto T; Sato H; Ogura H; Tanaka S; Umeda R Laryngoscope; 1988 Dec; 98(12):1334-8. PubMed ID: 2849005 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells. Takimoto T; Furukawa M; Hatano M; Umeda R Ann Otol Rhinol Laryngol; 1984; 93(2 Pt 1):166-9. PubMed ID: 6324641 [TBL] [Abstract][Full Text] [Related]
9. Rescue of a biologically active Epstein-Barr virus from nonproducer cells. Takimoto T; Sato H; Ogura H; Glaser R Cancer Res; 1986 Apr; 46(4 Pt 2):2085-7. PubMed ID: 3004720 [TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanisms of establishment and disruption of Epstein-Barr virus latency]. Takada K Tanpakushitsu Kakusan Koso; 1989 Jun; 34(7):823-34. PubMed ID: 2552500 [No Abstract] [Full Text] [Related]
11. Epstein-Barr virus (EBV), lymphocytes and transformation. Zeuthen J J Cancer Res Clin Oncol; 1983; 106(1):1-11. PubMed ID: 6309856 [No Abstract] [Full Text] [Related]